The IPO Buzz: Obesity-Focused Kailera Therapeutics Sets $500 Million IPO

Kailera Therapeutics (KLRA Proposed), which is developing a weekly GLP-1 shot and a daily pill to help people lose weight, launched its $500 million IPO with an S-1/A filing early today – Monday, April 13, 2026. Kailera Therapeutics disclosed the terms – 33.33 million shares at a price range of $14.00 to $16.00 per share – in the SEC filing. At pricing, Kailera Therapeutics would have a mar..

Read more April 13, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Maywood Acquisition Corp. 2 MYXXU D. Boral Capital 10.0 10.00 10.00 $ 100.0 mil 4/14/2026 Tuesday S/O S/O
Arxis, Inc. ARXS Goldman Sachs/Morgan Stanley/Jefferies/Citigroup/RBC Capital Markets/Baird/Guggenheim Securities/Wells Fargo Securities/William Blair/Rothschild/Wolfe Nomura Alliance 37.7 25.00 28.00 $ 1000.0 mil 4/16/2026 Thursday S/O S/O
Madison Air Solutions MAIR Goldman Sachs/Barclays/Jefferies/Wells Fargo Securities/BofA Securities/Citigroup/Baird/RBC Capital Markets/Guggenheim Securities/Santander/Wolfe | Nomura Alliance/CIBC Capital Markets 82.7 25.00 27.00 $ 2150.0 mil 4/16/2026 Thursday S/O S/O
Read more

Last 100 IPOs - April 12, 2026

Number of IPOs priced : 100
Number Up: 40
Number Down: 57
Number Unchanged: 3
Percentage Change From Issue Price: -15.46%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - April 12, 2026

Number of IPOs priced (Excluding 62 units) : 39
Number Up: 15
Number Down: 24
Number Unchanged: 0
Total Return From Issue Price: -6.61%
The Nasdaq Composite Index YTD % Change 35.22%